Small Molecules and others
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
28
NCT04683354
Study of HL-085 in Patients With Advanced Solid Tumor Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 23, 2020
Completion: Dec 8, 2022